L
OWER TESTOSTERONE concentrations have been associated with lower scores on tests of cognitive ability (1, 2) and the subsequent development of Alzheimer's disease (AD) (3) . Testosterone deficiency modulates neuronal processes capable of increasing the risk for AD (4) , and beneficial effects of testosterone supplementation have been reported on specific parameters of cognition in older men (5, 6) . The apolipoprotein E (APOE) ⑀4 allele is thought to be the major genetic risk factor for AD (7) and may independently modulate normal age-related cognitive change (8) . An association among low testosterone, APOE ⑀4, and AD has been reported (9), but it is not known whether testosterone and APOE ⑀4 interact to modulate cognition in men before the development of AD or whether differential effects of testosterone on cognition exist that are influenced by the absence or presence of ⑀4. We investigated the association among testosterone concentrations, genetic risk for AD, and cognitive abilities in healthy older men.
Patients and Methods Patients
Our institutional ethics committee approved this study and informed consent was obtained from participants. Community-dwelling men over 55 yr of age with no history of cognitive impairment, dementia, or other major medical illness were recruited. Exclusion criteria were hormonesuppressive therapy, testosterone therapy, medications known to affect bone metabolism within the past 3 months, significant prostate disease, abnormal liver function, hypothyroidism, major sleep disturbance, consumption of alcohol greater than 21 U/wk, psychiatric disorders, stroke, JCEM is published monthly by The Endocrine Society (http://www. endo-society.org), the foremost professional society serving the endocrine community.
head injuries, scores 80 or less on the Cambridge Cognitive Assessmentrevised (CAMCOG-R) (10) (identifying frank cognitive deficits), and 1.5 sd or greater below the mean for age on measures of verbal learning and memory (identifying mild cognitive impairment). After these exclusions there were 45 healthy men studied.
Procedures
Information concerning: current medical problems, medications, lifestyle factors, and years of formal education (cumulative years of primary, secondary, and tertiary education) were obtained, and blood pressure and body mass index (kilograms per square meter) was measured. Blood samples were collected between 0830 and 1030 h after overnight fasting. A standard breakfast (energy value 938 kJ) was provided before cognitive testing of constructs cited as relevant in the AD literature (11) and parameters influenced by testosterone concentrations (1, 2, 5, 6).
Biochemical assessments. Total testosterone concentrations were determined by coated tube RIA (Coat-A-Count, Diagnostic Products Corp.-BioMediq, Doncaster, Australia) with coefficient of variation being 8.9% at 2.5 nmol/liter and 8.5% at 14 nmol/liter. SHBG concentrations were determined via chemiluminescent immunoassay on an Immulite 2000 analyzer (Diagnostic Products Corp.-BioMediq) with coefficient of variation of 6.8% at 5.1 nmol/liter and 9.3% at 82.5 nmol/liter. Free testosterone (FT), specifically the fraction not bound to either SHBG or albumin, was calculated using a previously validated method (12) .
APOE genotyping. Peripheral blood leukocyte DNA was extracted and APOE genotyping was performed as previously described (13) .
Mood assessments. Depressive symptomatology was assessed via the Geriatric Depression Scale (14) . Current anxiety levels were assessed via the State Anxiety Scale from the Spielberger State Trait Anxiety Inventory (15) .
Neuropsychological tests
The National Adult Reading Test (16) was administered to derive an estimate of full-scale intelligence quotient (FSIQ) to control for differences in reading and estimated intellectual ability. The following tests were administered to obtain the listed cognitive constructs:
1. General cognition. CAMCOG-R (10) total score was analyzed to obtain an index of performance on orientation, memory, language, praxis, attention, tactile perception, calculation, abstract thinking, and visual perception tasks.
Immediate memory.
Immediate recall for verbal information on Wechsler Memory Scale-Third Edition (WMS-III) (17) Wordlists and visual information on the visual reproduction (VR) subtests was analyzed.
Delayed memory.
Comprised delayed recall, recognition, and percentage retention of verbal and visual information over a 25-min delay period (via the WMS-III Wordlists and VR subtests respectively). Scores on VR copy condition were used to control for differences in visuospatial ability between participants and as a statistical covariate in the visual memory data analyses.
Executive functioning, working memory, and attention (EFWMA). The Delis and Kaplan Executive Function System (D-KEFS) Color-Word
Interference Test (18) , color-naming, word-reading, inhibition, and inhibition-switching components were administered in series to obtain measures of executive functioning. Completion times for inhibition and inhibition switching were analyzed. To assess attention and working memory, total correct responses on the WMS-III letter number sequencing (17) were analyzed.
Verbal fluency.
Total correct responses on the D-KEFS verbal fluency test (18) (letter fluency, category fluency, and category switching conditions) and the percentage switching accuracy and errors made across all three conditions were analyzed.
A priori composites were calculated for each construct by converting raw scores for each participant on each test to age-adjusted scaled scores according to established norms (17, 18) and averaging the scaled scores. Composites reflecting broader constructs are more appropriate measures of cognitive ability and exhibit higher reliability than the individual components represented by single neuropsychological tests (19) . These constructs were used as dependent variables in hierarchical linear regression analyses to examine the FT by APOE ⑀4 status interaction on cognition.
Statistical analyses
Data were analyzed using the Statistical Package for Social Sciences (version 11.5; SPSS Inc., Chicago, IL). Cohort characteristics were explored via one-way ANOVA for continuous data and using the Pearson method for 2 ϫ 2 contingency tables ( 2 ) for categorical data. Homogeneity of variance and normality of data distributions were evaluated for FT and neuropsychological data in the groups [⑀4 carriers (⑀4ϩ) vs. noncarriers (⑀4Ϫ)]. Analysis of covariance/multivariate analysis of covariance (MANCOVA) was conducted to compare the effect of ⑀4 status (absence vs. presence) on FT, measures of mood, and cognitive performance, separately. Where appropriate, age and/or VR total copy score served as statistical covariates. The interaction between FT and ⑀4 status on composites of cognitive functioning was further examined via hierarchical linear regression analyses. Main effects involving FT concentrations were subsequently explored via Pearson's correlation coefficient (r).
Results
Characteristics of the cohort stratified by ⑀4 status are reported in Table 1 . The ⑀4ϩ group was significantly older than the ⑀4Ϫ group [F (1, 43) 
Evaluation of group differences
Analysis of covariance was performed using FT as the dependent variable and ⑀4 status as the independent variable, with age as a statistical covariate. Age significantly influenced FT [F (1, 42) ϭ 8.79, P ϭ 0.01]. After adjusting for age, there was no significant effect of ⑀4 status on FT [F (1, 42) ϭ 2.95, P ϭ 0.09]. Unadjusted group means and sds for ⑀4ϩ and ⑀4Ϫ groups for FT are presented in Table 1 .
Mood
MANCOVA was performed to examine group differences on anxious and depressed mood. After adjusting for age, there was no significant effect of ⑀4 status on depressed and anxious mood (F (2, 41) ϭ 1.18, P ϭ 0.32). The statistical covariate age did not influence mood (F (2, 41) ϭ 0.08, P ϭ 0.92).
Cognitive performance
Separate MANCOVAs were performed using the individual measures of cognitive functioning as dependent variables, with age and VR total copy score as statistical covariates where appropriate. The ⑀4ϩ and ⑀4Ϫ groups performed similarly on general cognition (CAMCOG-R total score), visual memory (WMS-III VR immediate and delayed recall, percentage retention, and recognition indices), EFWMA (WMS-III letter number sequencing total recall and D-KEFS inhibition and inhibition-switching completion times), and verbal fluency (D-KEFS verbal fluency test indices).
Significant group differences emerged on verbal memory performance. MANCOVA was performed using raw scores on the WMS-III Wordlists immediate and delayed recall, percentage retention, and recognition indices as dependent variables. Age significantly influenced these dependent variables [F (4, 39) ϭ 3.42, P ϭ 0.02]. After adjusting for age, the overall MANCOVA was significant with respect to the influence of ⑀4 status [F (4, 39) ϭ 3.22, P ϭ 0.02] on these four measures of verbal memory. Because the overall MANCOVA was significant, subsequent analysis of each individual dependent variable showed significant differences in scores between ⑀4ϩ and ⑀4Ϫ groups, on delayed recall [F (1, 42) The interaction between ⑀4 and FT on cognitive performance in the cohort was explored via hierarchical linear regression analyses, using FT, ⑀4 status, and ⑀4 ϫ FT as predictors of the following: 1) CAMCOG-R total score; 2) immediate memory; 3) delayed memory; 4) EFWMA; and 5) verbal fluency constructs. Hierarchical linear regression models are presented in Table 2 . In line with the previous MANCOVA analyses, ⑀4 status was significantly related to delayed memory performance. The ⑀4 ϫ FT interaction was significantly related to performance on the CAMCOG-R and EFWMA. These ⑀4 ϫ FT interactions were subsequently explored within ⑀4ϩ and ⑀4Ϫ groups by calculating separately the correlation coefficient (r).
The linear relationship between CAMCOG-R scores and FT within the ⑀4Ϫ and ⑀4ϩ groups is summarized in Fig. 1,  A and B, respectively. CAMCOG-R scores positively correlated with FT (r ϭ 0.46, n ϭ 29, P ϭ 0.01) in the ⑀4Ϫ group. There was significant negative correlation between FT concentrations and EFWMA in the ⑀4ϩ group (r ϭ Ϫ0.58, n ϭ 16, P ϭ 0.02), as shown in Fig. 1 , C and D.
Discussion
We systematically investigated the interaction between ⑀4 status and testosterone concentrations on cognition in apparently healthy older men. No difference in FT between the groups was noted in this cohort. Consistent with previous findings (20) , we observed that APOE ⑀4 carriers had lower scores on delayed recall for verbal information compared with non-⑀4 carriers. The novel finding is the interaction between FT and ⑀4 status on general cognition and EFWMA. In cognitively healthy older men without the ⑀4 allele, FT levels were positively correlated with general cognitive ability (i.e. CAMCOG-R scores). By contrast, in men who possess the ⑀4 allele, FT levels correlated negatively with EFWMA. These statistically significant observations are of potential clinical relevance as testosterone supplementation has been postulated to have beneficial effects on cognition (5, 6); however, this was not addressed here. Because higher testosterone concentrations were associated with lower performance on EFWMA in ⑀4 carriers, testosterone supplementation may not be beneficial in this group (who are at higher relative risk for AD). It may be necessary to stratify men by ⑀4 status when examining the relationship between testosterone and cognition or when designing interventional trials of testosterone replacement for the prevention of cognitive decline in older men.
Particular strengths of this study were the careful case selection, allowance for potential confounders including mood, detailed neuropsychological assessments, and the examination of a cohort free of cognitive impairment and dementia. Additionally, composite measures of cognitive performance were determined a priori and used to increase the validity of our analysis. Limitations of this study are the relatively small sample size, the cross-sectional nature, and the need to adjust for age differences between the groups. A larger study with follow-up to provide a longitudinal or prospective component would be highly desirable to extend our present findings.
Briefly, we observed an interaction between testosterone and APOE ⑀4 on cognition in healthy older men. In men not possessing an ⑀4 allele, higher testosterone concentrations were associated with better general cognition. However, higher testosterone concentrations in men who possessed an ⑀4 allele had lower performance on executive functioning, working memory, and attention tasks. APOE ⑀4 status should be taken into account when investigating the relationship between androgens and cognition in older men. 
